30 May 2023

General conditions the extension of the transition period

  • Compliance with Directive 90/385/EEC or Directive 93/42/EEC.
  • No significant changes in terms of design and intended use.
  • No unacceptable risk to the health or safety of patients, users or third parties.
  • 26 May 2024: implementation of a quality management system.
  • 26 May 2024: application for certification.
  • 26 September 2024: Notified Body and Manufacturer have signed agreement.

Devices with certificate or declaration of conformity issued before 26 May 2021

  • 31 December 2027: high risk devices, i.e. Class III and Class IIb implantable devices, with exceptions.
  • 31 December 2028: medium and low risk devices, i.e. Class IIb, Class IIa and Im, Is and Ir.
  • 26 May 2026: custom Class III implantable devices.

Medical Devices with certificate or declaration of conformity expired before 20 March 2023

  • Signature of the agreement between Manufacturer and Notified Body for MDR certification.
  • Granting of an exemption by the Competent Authority to the Manufacturer.